Background: Immune thrombocytopenia (ITP) is an acquired hematological disorder that is developed secondary to the production of auto-antibodies against platelets leading to isolated thrombocytopenia, in the absence of other causes of thrombocytopenia such as drugs, infections, malignancy, or other autoimmune diseases.Objective: This study aimed to determine serum levels of IL-17 and evaluate its prognostic significance in children with immune thrombocytopenia. Subjects and methods: A case control study carried out in Pediatric Hematology Outpatient Clinic, Zagazig University Hospitals during the period from September 2019 to August 2020. It included 100 subjects who were divided into 2 group; 50 children with ITP and 50 age and sex matched healthy children as a control group. Results: In this study, newly diagnosed patients with ITP had significantly higher levels of IL-17 compared to persistent and chronic patients with ITP (554.3, 259.9 and 158.6 pg/ml in in newly diagnosed ITP, persistent ITP and chronic ITP respectively, p<0.001). Conclusion:We concluded that serum IL-17 predicts susceptibility to ITP in Egyptian children with ITP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.